RiceBran Technologies (RIBT): Price and Financial Metrics
RIBT Price/Volume Stats
| Current price | $0.23 | 52-week high | $1.36 |
| Prev. close | $0.18 | 52-week low | $0.07 |
| Day low | $0.18 | Volume | 16,900 |
| Day high | $0.23 | Avg. volume | 51,310 |
| 50-day MA | $0.32 | Dividend yield | N/A |
| 200-day MA | $0.76 | Market Cap | 1.49M |
RIBT Stock Price Chart Interactive Chart >
RIBT Stock Summary
- With a market capitalization of $2,173,958, RICEBRAN TECHNOLOGIES has a greater market value than just 1.47% of US stocks.
- RICEBRAN TECHNOLOGIES's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.33% of US listed stocks.
- With a price/sales ratio of 0.06, RICEBRAN TECHNOLOGIES has a higher such ratio than only 1.65% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to RICEBRAN TECHNOLOGIES, a group of peers worth examining would be VC, SGA, SFIX, REX, and BEEM.
- RIBT's SEC filings can be seen here. And to visit RICEBRAN TECHNOLOGIES's official web site, go to www.ricebrantech.com.
RIBT Valuation Summary
- RIBT's price/earnings ratio is -0.2; this is 101.05% lower than that of the median Consumer Defensive stock.
- Over the past 243 months, RIBT's price/earnings ratio has gone down 0.
Below are key valuation metrics over time for RIBT.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| RIBT | 2023-10-24 | 0.1 | 2.8 | -0.2 | -0.5 |
| RIBT | 2023-10-23 | 0.1 | 2.6 | -0.1 | -0.4 |
| RIBT | 2023-10-20 | 0.1 | 2.9 | -0.2 | -0.5 |
| RIBT | 2023-10-19 | 0.1 | 2.8 | -0.2 | -0.5 |
| RIBT | 2023-10-18 | 0.1 | 3.4 | -0.2 | -0.5 |
| RIBT | 2023-10-17 | 0.1 | 2.8 | -0.2 | -0.5 |
RIBT Growth Metrics
- Its 2 year revenue growth rate is now at 28.84%.
- Its year over year price growth rate is now at -59%.
- Its 3 year revenue growth rate is now at 88.26%.
The table below shows RIBT's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 39.044 | -6.072 | -11.583 |
| 2022-06-30 | 35.701 | -4.52 | -11.754 |
| 2022-03-31 | 33.085 | -4.007 | -11.056 |
| 2021-12-31 | 31.131 | -4.198 | -8.949 |
| 2021-09-30 | 29.894 | -2.703 | -5.519 |
| 2021-06-30 | 28.145 | -2.991 | -6.08 |
RIBT Price Target
For more insight on analysts targets of RIBT, see our RIBT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $1.50 | Average Broker Recommendation | 1.5 (Moderate Buy) |
RiceBran Technologies (RIBT) Company Bio
RiceBran Technologies researches and develops rice bran-based nutrients. The Company markets proprietary whole food dietary supplements derived from nutrient-dense stabilized rice bran.
Latest RIBT News From Around the Web
Below are the latest news stories about RICEBRAN TECHNOLOGIES that investors may wish to consider to help them evaluate RIBT as an investment opportunity.
Unmasking the Value Trap: A Comprehensive Analysis of RiceBran Technologies (RIBT)Is RiceBran Technologies a Hidden Gem or a Potential Value Trap? |
RiceBran Technologies Reports Second Quarter 2023 Results/ RiceBran Technologies (NASDAQ:RIBT) ("RiceBran" or the "Company"), an innovator in the development and manufacture of nutritional and functional ingredients derived from rice, barley and oats, today announced financial results for the second quarter ended June 30, 2023. |
RiceBran Technologies Adopts Tax Benefits Preservation Plan Designed to Protect the Availability of Its Tax Benefits/ RiceBran Technologies (NASDAQ:RIBT) ("RiceBran" or the "Company"), a global leader in the development and manufacture of nutritional and functional ingredients derived from rice and other small and ancient grains for human food, nutraceutical, pet care and equine feed applications, today announced that its Board of Directors (the "Board") has adopted a Tax Benefits Preservation Plan (the "Tax Plan"). |
RiceBran Technologies Sells SRB BusinessRiceBran Technologies (NASDAQ:RIBT) ("RiceBran" or the "Company"), a global leader in the development and manufacture of nutritional and functional ingredients derived from rice and other small and ancient grains for food, nutraceutical, pet care and equine feed applications, today announced that it has sold its stabilized rice bran ("SRB") business for total consideration of approximately $3.5 million, consisting of $1.8 million in cash and the |
20 Countries with Highest Rice Consumption Per CapitaIn this article, we will be covering the top 20 countries with highest rice consumption per capita. If you want to skip our detailed analysis of the rice industry and consumption trends, go directly to the Top 5 Countries with Highest Rice Consumption Per Capita. Rice is one of the most widely consumed staple foods in the world, […] |
RIBT Price Returns
| 1-mo | -37.18% |
| 3-mo | -58.36% |
| 6-mo | -73.38% |
| 1-year | -79.82% |
| 3-year | -96.18% |
| 5-year | -99.28% |
| YTD | -69.12% |
| 2022 | -78.66% |
| 2021 | -42.79% |
| 2020 | -58.50% |
| 2019 | -51.00% |
| 2018 | 102.70% |
Continue Researching RIBT
Want to do more research on RiceBran Technologies's stock and its price? Try the links below:RiceBran Technologies (RIBT) Stock Price | Nasdaq
RiceBran Technologies (RIBT) Stock Quote, History and News - Yahoo Finance
RiceBran Technologies (RIBT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...